Six to 12 h after IP injection of 400 mg/kg of D-galactosamine in rats a 5-fold increase in plasma insulin was observed. In addition, impaired glucose assimilation was present after an IV load in spite of unchanged fasting glucose levels. In streptozotocin-diabetic rats (100 mg/kg IV) plasma insulin remained diminished 12 h after induction of Dgalactosamine hepatitis. Under identical conditions of preparation and incubation, the liver plasma membranes of D-galactosamine-treated rats, in both normal and diabetic states, bound only 40-60% as much insulin per mg of membrane protein as those of the control rats. Scatchard analysis suggested that this was due to a decrease in the number of receptor sites in the membranes of the D-galactosamine-injected rats. No difference in the insulin degrading capacity and in insulin-receptor dissociation of the plasma membranes between control and D-galactosaminetreated groups was found. These data suggest that a reduction in the number of hepatic insulin receptors in galactosamine hepatitis can lead to insulin resistance and hyperinsulinaemia.
Studies on the obese-hyperinsulinaemic syndrome in animals [1, 2] and patients [3, 4] , and on insulindeficient animals [5, 6] and humans [7] , showed an inverse relationship between plasma insulin concentration and the number of specific insulin receptors of target tissues: a high plasma insulin level reduced the insulin binding capacity of the target cells and vice versa. Under these conditions a change in the plasma insulin concentration is thought to be the primary event [1, 2, 8] . On the other hand, a primary alteration at the insulin receptor site has not yet been reported.
In animals, IP-injected D-galactosamine induces acute hepatitis which is biochemically and morphologically similar to human virus hepatitis [9] . As early as 3 to 6 h after the injection of D-galactosamine, distinct alterations of the protein and phospholipid metabolism of the liver plasma membrane [10] and impairment of hepatic glycoprotein metabolism have been observed [11] . In addition, 24 h after galactosamine injection hyperinsulinaemia was found [12] . It seemed likely that along with these metabolic changes alterations of the hepatic insulin receptor, a glycoprotein [13] [14] [15] , could occur. This would allow the possibility of inducing an insulin receptor defect in the liver and to study its possible consequences.
Materials and Methods

Animals
Male Wistar rats (Jautz, Kisslegg, FRG) weighing between 130 and 170 g were used. The animals were on a commercial diet (Altromin, Altromin GmbH, Lage-Lippe, FRG), water was given ad libimm. The rats were deprived of food overnight before each experiment.
Chemicals and Insulin Preparations
D-galactosamine hydrochloride (puriss.) was purchased from C. Roth (Karlsruhe, FRG). Adenosine 5'-monophosphate disodium salt, adenosine 5'-triphosphate disodium salt and glucose-6-phosphate were from Beohringer Mannheim (Mannheim, FRG), p-nitrophenylthymidine 5'-monophosphate was from Sigma Chemicals Co. (St. Louis, Mo., USA) and human albumin from the Swiss Red Cross (Berne, Switzerland). Streptozotocin- 
Experimental Procedures
Animal Treatment: In order to induce hepatitis the rats received a single IP injection of 400 mg/kg of D-galactosamine-HC1 3, 6, 12 or 24 h before the liver was removed. Diabetes was induced by IV administration of 100mg of streptozotocin-HC1 (dissolved in 0.154mol/1 NaC1, pH 4.0) per kg body wt. 6 days before the animals were killed. Control groups were injected with identical volumes of 0.154mol/1 NaCl-solution IP or IV, respectively. Blood samples were obtained from anaesthetized rats (10rag Nembutal intraperitoneally) by aortic or portal vein puncture. Blood glucose was determined by the hexokinase method [16] , plasma aspartate aminotransferase according to Bergmeyer [17] , plasma immunoreactive insulin was measured by the Herbert modification [18] of the Yalow-Berson radioimmunoassay [19] using a rat insulin standard.
Intravenous Glucose Tolerance Test: IV glucose tolerance test was performed after a fasting period of 24 h. Rats were anaesthetized and 0.5 g/rat of glucose was given as a 50% solution via a superficial jugular vein within 30 sec. Venous (tail vein) blood samples were taken at various intervals between -5 and 180 rain for glucose determination.
Plasma ~Vlembrane Isolation:
Liver plasma membranes were isolated by a modification of thc methods of Neville [20] and Ray [21 ] as described before [10] . Four livers were pooled for onc membrane preparation. The purity of the plasma membrane fractions was checked by electron microscopy and by several enzyme markers for plasma membrane (5'-nucleotidase [22] , Na ~ -~ K=-ATPase [23] , alkaline phosphatase [24] ), mitochondria (succinate dchydrogenase [25] ) and endoplasmatic reticulum (glucose-6-phosphatase [26] ). Protein was determined by the method of Lowry ct al. [27] with bovine serum albumin as a standard.
Binding &udies: The method employed in the binding studies has been described in detail [28] . In brief, insulin binding to rat liver plasma membranes was performed in duplicate samples at 25 ~ containing 40 mmol/1 Tris-HC1 buffer, pH 7,4, 20 mg/ml of human serum albumin, 2 ng of [a25I]-insulin, unlabelled insulin at various concentrations from 0 to 40 ~tg/ml, and plasma membranes corresponding to 40480 ag protein, in a volume of 500 ~tl. The reaction was started by addition of the plasma membranes. Except when stated otherwise, membranes were incubated for 120 rain while gently shaken. The incubation was terminated by centrifugation through silicone oil. All data are reported as specific binding, i. c. after subtraction of nonspecific binding as determined in the presence of 40 ag/ml of insulin (5-10% of total).
Flectron Microscopy: Plasma membrane fractions were fixed in 3% glutaraldehyde followed by 1% osmium tetroxide, both in phosphate buffered solution at pH 7.4. Pellets were dehydrated in a graded series of ethanol and embedded in epon. Thin sections were stained with lead citrate and examined in an Elmiskop 101 E.M. (Siemens). Results are presented as mean '-SEM. Statistical analysis of the differences between control, diabetic and D-galactosaminetreated groups was performed using Student's t-test.
Results
Plasma Aspartate Aminotransferase and Light Microscopic Features of the Liver after D-Galactosamine Administration
The continuous increase in the activity of aspartate aminotransferase from 3 to 24 h after the injection of D-galactosamine indicates the development of mild hepatitis (Table 1) . By light microscopy minimal morphological change with Councilman bodies and atypical dense bodies in parenchymal liver cells, single cell necroses, and inflammatory cells were seen not sooner than 6 h after the injection of D-galactosamine. The number of single cell necroses and 
Fasting Blood Glucose, Fasting Plasma Insulin and Intravenous Glucose Tolerance Test in D-Galactosamine-Treated Rats
After an overnight fast and 3 h after the administration of D-galactosamine the blood glucose level was decreased and the plasma insulin concentration was slightly diminished (Table 1 ). 6 and 12 h following D-galactosamine, however, the plasma insulin level was elevated about 5-fold, a two-fold increase still remaining after 24h. Portal insulin levels were measured in a control group, and 12 h after galactosamine administration. They were 45 __+ 7.8 ~tU/ml for controls (n = 8), and 215 + 36 in galactosaminetreated rats (n = 8). In 24 h starved rats blood glucose was also decreased 6 and 12 h after D-galactosamine injection (Table 2) . While 6 hours after Dgalactosamine administration no significant change in glucose tolerance could be detected, a slower fall was evident after 12h with significant differences between 30 and 180 min following IV glucose administration ( Table 2) .
Characteristics of Hepatic Plasma Membranes from D-Galactosamine-Treated Rats
As shown in Table 3 , the liver plasma membrane fractions of control and D-galactosamine-treated rats were comparable in the pattern of marker enzymes for plasma membranes (5'-nucleotidase, alkaline phosphatase, (Na + + K+)-ATPase), mitochondria (succinate dehydrogenase), and endoplasmatic reticulum (glucose-6-phosphatase). In addition, electron microscopic examination of the various plasma membrane fractions showed no evidence for significant organeIle contamination ( When bound insulin was plotted as a function of hormone concentration, insulin binding in D-galactosamine-treated animals was proportionally decreased to 40-60% in comparison to that of control animals over the range of 0.4 to 800 ng insulin per ml (Fig. 3A) . The greatest reduction in specific insulin binding to liver plasma membranes in Dgalactosamine-treated rats was seen after 12 h. The Scatchard plot [29] shows a parallel shift, which indicates a decrease in receptor concentration after galactosamine treatment (Fig. 3 B) . A linear correlation of specific and non-specific binding to plasma membrane concentration (20 Fg to 480 ~tg of membrane protein) was evident for all membrane preparations used (Fig. 4) .
The insulin-degrading activities of the plasma membrane fractions were determined by measuring the formation of radioactive products soluble in 0.6reel/1 trichloroacetic acid from [t25I]-labelled insulin. In all groups [~25I]-insulin degradation by hepatic plasma membranes was between 0.005 and 0.086% of total radioactivity; no significant difference could be seen between control and D-galactosamine-treated groups.
Studies on the dissociation of hormone-receptor complexes were performed by preincubating the membranes in the presence of 2 ng [125I]-insulin followed by the addition of 20 ~g of unlabelled insulin. Further incubation for 120 min resulted in identical dissociation kinetics in control and D-galactosaminetreated animals (Fig. 5) .
Insulin, Glucose and .dspartate AminotransJ'erase in the Diabetic" Rat 12 h after D-Galactosamine Administration
In diabetic rats (Table 4 ) D-galactosamine induced a greater increase in aspartate aminotransferase activity as compared to normal rats (Table 1) . Fasting blood glucose was increased to 18.8 retool/1 in diabetic rats with no change after administration of Dgalactosamine. Plasma insulin concentration in diabetic rats remained low after the injection of Dgalactosamine. 
Characteristics of Hepatic Plasma Membranes from Diabetic Rats with and without D-Galactosamine Treatment
With respect to the activities of marker enzymes the membrane fractions isolated from diabetic rats with and without D-galactosamine-injection were of similar purity and comparable to those from control rats (Table 3) . No difference could be observed in the activities of succinate dehydrogenase and glucose 6-phosphatase. In diabetic rats the specific activity of 5'-nucleotidase of liver plasma membranes was reduced to 51.6 + 13.8 ~tmol phosphate liberated/h per mg protein at 37~ (n = 11, p < 0.001). 12h after D-galactosamine injection a further decrease to 40.5 ___ 0.5 (n = 6) could be seen. In contrast, the specific activity of the alkaline phosphatase of the membrane fraction was enhanced to 339 + 85 ~tmol of phosphate liberated/h per mg protein at 37~ (p < 0.05) with no change after additional administration of D-galactosamine. These alterations of both plasma membrane marker enzymes in streptozotocin-induced diabetes in rats have been reported before [30] . Again, electron microscopy did not reveal any difference in membrane structure or contamination with other organelles. In diabetic rats the yield of liver plasma membranes was 0.98 + 0.22 mg of membrane protein per g wet wt. and 0.63 _+ 0.16rag at 12 h after D-galactosamine administration.
Insulin Binding in Diabetic Rats after D-Galactosamine Treatment
As shown in Fig. 6 the same pronounced decrease in specific insulin binding to membranes 12 h after the injection of D-galactosamine was observed in diabetic rats. In addition, Scatchard analysis again showed identically shaped curves for diabetic and diabetic rats treated with D-galactosamine.
Discussion
Insulin resistance is defined as diminished sensitivity of target tissues to endogenous or exogenous insulin. Consequently, the hallmarks of insulin resistance are elevated plasma insulin concentration in the presence of normoglycaemia and/or enhanced insulin demand in insulin-dependent diabetics. In acute virus hepatitis in man increased plasma insulin levels in addition to impaired glucose tolerance have been reported. These results were interpreted as an expression of insulin resistance due to a reduction in functionally normal hepatocytes [31, 32] .
During the course of D-galaetosamine-induced experimental hepatitis a 5-fold increase in plasma insulin concentration 6 to 12 h after the injection of the aminosugar could be seen (Table 1) . This elevation of plasma insulin together with the development of glucose intolerance (Table 2) suggests insulin resistance. According to light microscopical findings, cellular damage due to galactosamine in other target organs for insulin such as muscle and adipose tissue is unlikely (R. Lesch: personal communication). This points to the selectively affected liver cell as the source of insulin resistance. In the liver, extensive cellular necroses could be considered as a major factor. However, at 6-12hours, where hyperinsulinaemia was already marked, necrosis was found to be negligible. Even at higher doses of galactosamine, a substantial degree of necrosis was observed only at a much later stage of hepatitis (> 24h) [33, 34] . The similar ratio of portal versus peripheral insulin (4.29 vs. 4.39 in control and 12 hgalactosamine-treated, respectively) also argues against extensive liver damage and excludes the possiblity of reduced insulin breakdown as a cause for peripheral hyperinsulinaemia in these animals.
In contrast to the morphological changes, pronounced inhibition of protein and RNA synthesis was already evident at 30-120 min [35] . The metabolic alterations of the liver cell include inhibition of glycoprotein synthesis [11] and distinct changes in protein and phospholipid metabolism of the plasma membrane /10]. These alterations in the composition of essential plasma membrane constituents may well account for the reduction in insulin binding sites observed in D-galactosamine-induced hepatitis. Since the insulin receptor of the liver plasma membrane seems to be a glycoprotein [13] [14] [15] , its effectiveness might be modulated by phospholipids, as discussed in the case of the effect of phosphatidylinositol upon receptors, which activate adenylate cyclase [36] . According to the time sequence after Dgalactosamine injection, the reduction of the number of insulin binding sites of liver plasma membranes at 3 h clearly precedes the increase in plasma insulin concentration (Table 1, Fig. 3 A) which is elevated at 6 h. In spite of this well-documented sequence of events, additional control studies in streptozotocininduced diabetic rats were performed. Though in diabetic animals no increase in plasma insulin concentration after D-galactosamine administration occurred (Table 4) , the binding of [125I]-insulin was also reduced to 40% of controls.
The present data can not exclude a possible role of hepatic factors which cause peripheral insulin resistance or changes in intermediary metabolism of the liver resulting in hepatic insulin resistance. Of other agents known to cause insulin resistance, glucagon, cortisol and free fatty acids could be excluded since their levels were not significantly different (unpublished results). However, in considering all results presented herein, the most likely explanation is that the reduction in the number of hepatic insulin receptors leads to insulin resistance with a subsequent increase in plasma insulin.
